ARTICLE | Clinical News
DynaGen regulatory update
February 23, 1998 8:00 AM UTC
DYGN received notice of allowance for a U.S. patent covering the use of ImmuDyn, a lipid-based immunomodulator, to treat HIV. DYGN's Apex Pharmaceuticals Inc. subsidiary is developing ImmuDyn initiall...